Kairos Pharma, LTD. Quarterly Unrecognized Tax Benefits in USD from Q4 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Kairos Pharma, LTD. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2023 to Q4 2024.
  • Kairos Pharma, LTD. Unrecognized Tax Benefits for the quarter ending December 31, 2024 was $0.000.
Unrecognized Tax Benefits, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $0 $0 Dec 31, 2024 10-K 2025-04-15
Q3 2024 $0 Sep 30, 2024 10-Q 2024-11-14
Q4 2023 $0 Dec 31, 2023 10-K 2025-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.